journal article·2024-04-10Open access

Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry

Pei Zhang, Erik Niemelä, Sandra López Cerdá, Pasi Sorvisto, Jani Virtanen, Hélder A. Santos

Nano Letters· Volume 24· Issue 14

Abstract

Herein, we fabricate host-directed virus-mimicking particles (VMPs) to block the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells through competitive inhibition enabled by their interactions with the angiotensin-converting enzyme 2 (ACE2) receptor. A microfluidic platform is developed to fabricate a lipid core of the VMPs with a narrow size distribution and a low level of batch-to-batch variation. The resultant solid lipid nanoparticles are decorated with an average of 231 or 444 Spike S1 RBD protrusions mimicking either the original SARS-CoV-2 or its delta variant, respectively. Compared with that of the nonfunctionalized core, the cell uptake of the functionalized VMPs is enhanced with ACE2-expressing cells due to their strong interactions with the ACE2 receptor. The fabricated VMPs efficiently block the entry of SARS-CoV-2 pseudovirions into host cells and suppress viral infection. Overall, this study provides potential strategies for preventing the spread of SARS-CoV-2 or other coronaviruses employing the ACE2 receptor to enter into host cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Molecular Communication and Nanonetworks

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland

Finncure Oy, Lars Sonckin Kaari 14, Espoo 02600, Finland

Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands

Funding

Business Finland · ELY Centres project · FinnCure Ltd · Runar B?ckstr?m foundation

References (36)

Show source-provided references
1. 10.1038/s41591-022-02051-310.1038/s41591-022-02051-3 ↗
2. 10.1038/s41580-021-00418-x10.1038/s41580-021-00418-x ↗
3. 10.1038/s41423-020-0400-410.1038/s41423-020-0400-4 ↗
4. 10.1002/rmv.220710.1002/rmv.2207 ↗
5. 10.1021/acsnano.0c0683610.1021/acsnano.0c06836 ↗
6. 10.1038/nrmicro282010.1038/nrmicro2820 ↗
7. 10.3390/cells1002030010.3390/cells10020300 ↗
8. 10.1126/scisignal.129re810.1126/scisignal.129re8 ↗
9. 10.1038/nrmicro303610.1038/nrmicro3036 ↗
10. 10.1073/pnas.211989311910.1073/pnas.2119893119 ↗
11. 10.1016/j.cell.2020.02.05210.1016/j.cell.2020.02.052 ↗
12. 10.1038/s41586-020-2286-910.1038/s41586-020-2286-9 ↗
13. 10.1038/nrd.2017.16210.1038/nrd.2017.162 ↗
14. 10.1016/j.antiviral.2019.04.00610.1016/j.antiviral.2019.04.006 ↗
15. 10.1038/s41467-022-34111-010.1038/s41467-022-34111-0 ↗
16. 10.1038/s41588-023-01307-z10.1038/s41588-023-01307-z ↗
17. 10.1128/CMR.00168-1910.1128/CMR.00168-19 ↗
18. 10.1016/j.bj.2020.04.00710.1016/j.bj.2020.04.007 ↗
19. 10.1038/nature1311810.1038/nature13118 ↗
20. 10.1038/nature0505810.1038/nature05058 ↗
21. 10.1002/adma.20221125410.1002/adma.202211254 ↗
22. 10.1021/acs.langmuir.5b0279710.1021/acs.langmuir.5b02797 ↗
23. 10.1021/la035864n10.1021/la035864n ↗
25. 10.1038/s41467-020-20654-710.1038/s41467-020-20654-7 ↗
26. 10.3390/vaccines904039510.3390/vaccines9040395 ↗
27. 10.3389/fnins.2023.111784510.3389/fnins.2023.1117845 ↗
28. 10.3390/v1407136910.3390/v14071369 ↗
29. 10.1128/JVI.79.15.9470-9479.200510.1128/JVI.79.15.9470-9479.2005 ↗
30. 10.3390/cells1104062710.3390/cells11040627 ↗
31. 10.1038/s41433-020-0939-410.1038/s41433-020-0939-4 ↗
32. 10.1016/j.ejps.2020.10566810.1016/j.ejps.2020.105668 ↗
33. 10.1038/s41467-020-16048-410.1038/s41467-020-16048-4 ↗
34. 10.1038/s41596-020-0394-510.1038/s41596-020-0394-5 ↗
35. 10.1002/jmv.2840610.1002/jmv.28406 ↗
36. 10.1016/j.str.2022.07.00510.1016/j.str.2022.07.005 ↗